Institutional & Family Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $125K | Hold |
1,350
| – | – | 0.02% | 173 |
|
|
2024
Q1 | $129K | Hold |
1,350
| – | – | 0.02% | 165 |
|
|
2023
Q4 | $103K | Hold |
1,350
| – | – | 0.02% | 187 |
|
|
2023
Q3 | $93.5K | Hold |
1,350
| – | – | 0.02% | 182 |
|
|
2023
Q2 | $127K | Hold |
1,350
| – | – | 0.02% | 162 |
|
|
2023
Q1 | $112K | Hold |
1,350
| – | – | 0.02% | 168 |
|
|
2022
Q4 | $101K | Hold |
1,350
| – | – | 0.02% | 172 |
|
|
2022
Q3 | $112K | Hold |
1,350
| – | – | 0.02% | 162 |
|
|
2022
Q2 | $128K | Hold |
1,350
| – | – | 0.02% | 157 |
|
|
2022
Q1 | $159K | Hold |
1,350
| – | – | 0.03% | 161 |
|
|
2021
Q4 | $175K | Hold |
1,350
| – | – | 0.03% | 164 |
|
|
2021
Q3 | $153K | Hold |
1,350
| – | – | 0.02% | 201 |
|
|
2021
Q2 | $140K | Hold |
1,350
| – | – | 0.02% | 203 |
|
|
2021
Q1 | $113K | Hold |
1,350
| – | – | 0.02% | 252 |
|
|
2020
Q4 | $123K | Hold |
1,350
| – | – | 0.03% | 232 |
|
|
2020
Q3 | $108K | Hold |
1,350
| – | – | 0.03% | 221 |
|
|
2020
Q2 | $93K | Hold |
1,350
| – | – | 0.02% | 244 |
|
|
2020
Q1 | $85K | Hold |
1,350
| – | – | 0.02% | 224 |
|
|
2019
Q4 | $105K | Hold |
1,350
| – | – | 0.02% | 224 |
|
|
2019
Q3 | $99K | Hold |
1,350
| – | – | 0.02% | 216 |
|
|
2019
Q2 | $83K | Hold |
1,350
| – | – | 0.02% | 251 |
|
|
2019
Q1 | $86K | Hold |
1,350
| – | – | 0.02% | 262 |
|
|
2018
Q4 | $69K | Hold |
1,350
| – | – | 0.02% | 280 |
|
|
2018
Q3 | $78K | Hold |
1,350
| – | – | 0.02% | 302 |
|
|
2018
Q2 | $66K | Hold |
1,350
| – | – | 0.01% | 325 |
|
|
2018
Q1 | $63K | Buy |
+1,350
| New | +$58.6K | 0.01% | 305 |
|
Other funds holding EW
